Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

April 2014

Underpinning research published:

Mahtani KR, Heneghan CJ, Nunan D, Roberts NW. 
Vitamin K for improved anticoagulation control in patients receiving warfarin.
Cochrane Database of Systematic Reviews. 2014(5).

July 2014

Impact:

Anti Coagulation Europe (ACE) (UK) is a charity dedicated to supporting patients who take anticoagulant and antiplatelet therapies. The charity partnered with three other UK charities to form the AntiCoagulation Self-Monitoring Alliance and submitted written evidence, citing the reviews, to the Parliamentary Health Select Committee’s inquiry into the Management of Long-Term Conditions (2014). They cite the 2006 and 2010 systematic reviews on self-monitoring.

Impact:

Anticoagulation services and patient access to INR self-monitoring in the NHS in England - A report by the AntiCoagulation Self-Monitoring Alliance (July 2014) cite the 2006 Lancet review. 

August 2014

Impact:

British Society of Haematology – Patient self‐testing and self‐management of oral anticoagulation with vitamin K antagonists: guidance from the British Committee for Standards in Haematology.

The guidance cites the 2012 Lancet review on self-monitoring. Heneghan invited as co-author of the guideline.